Neuvotion, Inc., founded in 2019 and headquartered in the United States, is innovating within the Health Care industry with its mission of Restoring Independence. The company is leveraging cutting-edge technology that merges targeted neurostimulation with AI to develop groundbreaking solutions aimed at facilitating and restoring movement for patients facing movement disorders or impairments due to strokes or injuries.
Neuvotion’s products empower medical professionals by providing them with advanced tools to monitor and enhance patient recovery, supporting both in-person and remote treatment protocols. This approach not only enhances therapeutic outcomes but also sets a new standard in patient care.
Recently, Neuvotion secured a substantial $1.25M Seed Round investment on April 13, 2023. The investment came from notable backers, including Long Island Angel Network, Northwell Holdings, and Topspin Fund, underlining strong investor confidence in the company's potential to transform the rehabilitation landscape.